Shi-Yi Wang on Shifting End-of-Life Treatment Paradigms
Shi-Yi Wang, MD, PhD, assistant professor of Epidemiology at Yale School of Public Health, discusses the need for change in aggressive end-of-life cancer treatment.
Olanzapine Significantly Reduces CINV in Patients Receiving MEC
Reimagining Frailty Screenings in Head and Neck Cancer
Screening for Pain and Depression is Not Enough in Cancer Care
Niraparib-Based Triplet Therapy Offers OS Advantage in BRCA1/2+ mCRPC
